Results 101 to 110 of about 96,164 (192)

Heterogeneous outcomes in metabolic dysfunction-associated steatotic liver disease/steatohepatitis with type 2 diabetes: Rethinking risk and management approaches. [PDF]

World J Clin Cases
Zheng ZX, Huang SM.
europepmc   +1 more source

Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use [PDF]

, 2018
Maham Lodhi, Jaimin Amin, Sheila Eswaran
openalex   +1 more source

AI in steatohepatitis diagnostics: precision beyond the microscope. [PDF]

Ann Med Surg (Lond)
Ejaz A, Ahmed MM, Khalid M, Talha M, Waafira A.   +4 more
europepmc   +1 more source

Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose binge. [PDF]

Am J Physiol Gastrointest Liver Physiol
Viebahn GK, Khurana A, Freund L, Chilin-Fuentes D, Jepsen K, Rosenthal SB, Chatterjee S, Ellenrieder V, Hsu CL, Schnabl B, Hartmann P.   +10 more
europepmc   +1 more source

Attenuating effects of allantoin on oxidative stress in a mouse model of nonalcoholic steatohepatitis

, 2021
Zeinab Hamidizad, Azam Moslehi, Maryam Rastegarpanah   +2 more
openalex   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): New Perspectives on an Evolving Epidemic. [PDF]

J Clin Med
Lake-Bakaar G.
europepmc   +1 more source

Corrigendum to “An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug’s effect on cardiovascular disease and non-alcoholic steatohepatitis” [Diab. Res. Clin. Pract. 135 (2018) 102–110] [PDF]

, 2018
Mayer B. Davidson, Deyu Pan
openalex   +1 more source

Time-Restricted Feeding Is Not Effective in Modulating Fibrosis in a Male MASH Model. [PDF]

J Biol Rhythms
Flores Ramos S, Fogelson KA, Muti VB, Zhong W, Hu J, Hosseini M, Loomba R, Zarrinpar A.   +7 more
europepmc   +1 more source

Limited Utility of Plasma M30 in Discriminating Non-Alcoholic Steatohepatitis from Steatosis – A Comparison with Routine Biochemical Markers

, 2014
Wah‐Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva   +3 more
openalex   +2 more sources

Semaglutide for metabolic dysfunction-associated steatohepatitis (MASH): Estimating eligibility from the 2021-2023 National Health and Nutrition Examination Survey (NHANES). [PDF]

Hepatol Commun
Hughes JW, Levin JB, Sajatovic M, Sclair SN.   +3 more
europepmc   +1 more source